2006
DOI: 10.1038/sj.onc.1209443
|View full text |Cite
|
Sign up to set email alerts
|

Transforming growth factor alpha acts as a gliatrophin for mouse and human astrocytes

Abstract: Astrocyte death has been implicated in several neuropathological diseases, but the identification of molecules susceptible of promoting astrocyte survival has been elusive. We investigated whether transforming growth factor alpha (TGFa), an erbB1/EGFR ligand, which promotes glioma progression and affects astrocyte metabolism at embryonic and adult stages, regulates astrocyte survival. Primary serum-free astrocyte cultures from postnatal mouse and fetal human cortices were used. Transforming growth factor alpha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
32
0
1

Year Published

2006
2006
2014
2014

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(34 citation statements)
references
References 69 publications
1
32
0
1
Order By: Relevance
“…TGFa overexpression is found in about 80% of them, and is observed from the initial steps of their development (Junier, 2000), whereas the overexpression of erbB1 appears in 20-40% of them in later phases (Wechsler-Reya and Scott, 2001). We previously showed that TGFa acts as a gliatrophin on mouse and human cortical astrocytes, promoting their growth as well as their survival (Sharif et al, 2006b), in agreement with the recent report of increased astrocyte apoptosis in erbB1 knockout mice (Wagner et al, 2006). These results suggest that TGFa might participate in the early stages of tumoral transformation through the deregulation of astrocyte proliferation and apoptosis.…”
Section: Introductionsupporting
confidence: 90%
See 2 more Smart Citations
“…TGFa overexpression is found in about 80% of them, and is observed from the initial steps of their development (Junier, 2000), whereas the overexpression of erbB1 appears in 20-40% of them in later phases (Wechsler-Reya and Scott, 2001). We previously showed that TGFa acts as a gliatrophin on mouse and human cortical astrocytes, promoting their growth as well as their survival (Sharif et al, 2006b), in agreement with the recent report of increased astrocyte apoptosis in erbB1 knockout mice (Wagner et al, 2006). These results suggest that TGFa might participate in the early stages of tumoral transformation through the deregulation of astrocyte proliferation and apoptosis.…”
Section: Introductionsupporting
confidence: 90%
“…TGFa effect was fully reversed upon serum addition (not shown). To check for the specificity of TGFa effect, we evaluated the activation state of erbB1 that we previously evidenced to be activated up to 3 days of TGFa treatment (Sharif et al, 2006b). We observed that the activated, phosphorylated form of erbB1 was still detected after 7 DIV in the presence of TGFa, despite downregulation of the protein levels of the receptor (Supplementary Figure 1).…”
Section: Resultsmentioning
confidence: 95%
See 1 more Smart Citation
“…Several EGFR ligands have been identified including EGF, HB-EGF, and TGF-␣ (Kornblum et al, 1999;Sharif et al, 2006). Using specific neutralizing antibodies, we next attempted to identify which of these ligands may be involved in TWEAK-mediated astrocyte proliferation.…”
Section: Tweak and Fn14 Expression In Cns-derived Cellsmentioning
confidence: 99%
“…Transforming growth factor ␣ (TGF␣) is a critical regulator of astrocyte formation, and TGF␣ signaling is frequently deregulated in gliomas (Sibilia et al 1998;Junier 2000;Wechsler-Reya and Scott 2001). Prolonged exposure to TGF␣, which is overexpressed in earlier stages of glioma, can cause astrocytes in vitro to regress into neural progenitor-like cells (Sharif et al 2006(Sharif et al , 2007.…”
Section: Potential Mechanisms Involved In Erbb2 Reinduced Astrocytesmentioning
confidence: 99%